Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumoursCiro Celsa, Fable Zustovich, Jaekyung Cheon et al.|Journal of Hepatology|2023Cited by 62
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatmentCiro Celsa, Johann von Felden, Giuseppe Cabibbo et al.|Hepatology|2024Cited by 52
Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B DysfunctionClaudia Angela Maria Fulgenzi, Calogero Cammà, Bernhard Scheiner et al.|JAMA Oncology|2024Cited by 37
Temporal evolution of breast cancer brain metastases treatments and outcomesMichele Bottosso, Valentina Guarneri, Gaia Griguolo et al.|npj Breast Cancer|2025Cited by 6
172P Insights into male breast cancer: A 35-year mono-institutional retrospective study on adjuvant radiotherapy (RT)Carlo Alberto Giorgi, V. Guarneri, Luisa Bellu et al.|ESMO Open|2025Cited by 0